LEADER 01021nam0-22002891i-450- 001 990007247020403321 005 20021010 035 $a000724702 035 $aFED01000724702 035 $a(Aleph)000724702FED01 035 $a000724702 100 $a20021010d--------km-y0itay50------ba 101 0 $aita 200 1 $aFactoring, Leasing, Franchising, Venture capital, Leveraged buy-out, Hardship clause, Countertrade, Cash and carry,Merchandising, Know-how, Securitization$fAldo Frignani. 205 $a6. ed. amp. ed agg. 210 $aTorino$cGiappichelli$d1996. 215 $aXVIII, 602 p.$d24 cm 676 $a346.02 700 1$aFrignani,$bAldo$0115471 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990007247020403321 952 $aA-IV-F-59$b7899 dip.$fDDRC 959 $aDDRC 996 $aFactoring, leasing, franchising, venture capital, leveraged buy-out, hardship clause, countertrade, cash and carry,merchandising, know-how, securitization$9662458 997 $aUNINA DB $aGEN01 LEADER 02074nas 2200697-a 450 001 996218648703316 005 20230518213020.0 011 $a1932-2267 035 $a(OCoLC)70082347 035 $a(CKB)1000000000256983 035 $a(CONSER)--2006214697 035 $a(MiAaPQ)54423 035 $a(DE-599)ZDB2388888-X 035 $a(EXLCZ)991000000000256983 100 $a20060613a20079999 s-- a 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aJournal of cancer survivorship 210 $aNew York, N.Y. $cSpringer Science + Business Media$d2007- 300 $aRefereed/Peer-reviewed 300 $aTitle from journal information screen (Publisher's Web site, viewed July 3, 2007). 311 $a1932-2259 531 $aJ CANCER SURVIV 531 $aJ. CANCER SURVIV.-RES. PRACT 606 $aCancer$vPeriodicals 606 $aCancer$xTreatment$vPeriodicals 606 $aCancer$xPatients$vPeriodicals 606 $aContinuity of Patient Care 606 $aNeoplasms$xtherapy 606 $aQuality of Health Care 606 $aSurvival Rate 606 $aSurvivors 606 $aCancer$2fast$3(OCoLC)fst00845317 606 $aCancer$xPatients$2fast$3(OCoLC)fst00845411 606 $aCancer$xTreatment$2fast$3(OCoLC)fst00845538 606 $aKanker$2gtt 606 $aOverleving$2gtt 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 610 $aOncology 615 0$aCancer 615 0$aCancer$xTreatment 615 0$aCancer$xPatients 615 2$aContinuity of Patient Care. 615 2$aNeoplasms$xtherapy. 615 2$aQuality of Health Care. 615 2$aSurvival Rate. 615 2$aSurvivors. 615 7$aCancer. 615 7$aCancer$xPatients. 615 7$aCancer$xTreatment. 615 17$aKanker. 615 17$aOverleving. 676 $a616.99 906 $aJOURNAL 912 $a996218648703316 996 $aJournal of cancer survivorship$91974935 997 $aUNISA